Abstract: Tear fluid has rapidly evolved from an obscure biological matrix into a highly prized, minimally invasive source of complex biomarkers. Driven by advancements in

Abstract: The intersection of industrial computing and high-throughput cellular biology has reached a critical inflection point. Greenstone Biosciences has announced a strategic collaboration with Intel

Abstract: The frontier of precision medicine is shifting from what our genes say to how our environments talk to our genes. Backed by a £16

Abstract: The intersection of microbiome health and cancer treatment has taken a major step forward with the Royal Veterinary College (RVC) launching Europe’s first dedicated

Abstract: The high cost, complex infrastructure, and strict temperature requirements of cryopreservation remain significant bottlenecks for biobanks worldwide. To address these challenges, researchers from the

Abstract: The role of biobanking is undergoing a radical shift as it converges with artificial intelligence. Traditionally seen as static repositories, biobanks are now evolving

Abstract: The debate over whether our health is “written in our stars” or shaped by our daily habits has taken a provocative turn with the

Abstract: Traditionally, biobanks were used purely for “back-end” research to understand diseases. However, a major study of Geisinger’s MyCode initiative found that 3.4% of participants

Abstract: Conventional medicine often focuses on managing the symptoms of chronic diseases like diabetes and musculoskeletal decay rather than fixing the underlying damage. To move

Abstract: Most genetic research focuses on “additive” traits, where having one faulty gene copy slightly raises your risk for a disease. However, many of the